Deb just found an article about bladder ASPS met and posted it in the Other metastases here:
http://www.cureasps.org/forum/viewtopic.php?f=17&t=894
The article is avail. in the link there and also in the full text here:
www.rbrs.org/dbfiles/journalarticle_0927.pdf
and when I read it, I noticed that there is a description of the intestinal mets they know about:
" Only four cases of ASPS intestinal
metastases has been reported in
literature so far, the first by Sueyoshi
in 1996, affecting jejunum with gastrointestinal bleeding
associated (10). In 2001, Sabel et
al. described a case in small bowel,
causing polyposis and intussuseption
in a 42-year-old male with previous
history of ASPS metastatic to
lung and brain (11). Zilber et al. in
2003 found the first case of colic
metastases in a 43-year-old woman
with a leg primary tumor more than
15 years before and multiple lung
and brain metastases. She was
found to have caecal metastases,
revealed by anaemia, and was treated
by laparoscopic right colectomy
(12). In 2009, Banihani et al. published
a case about a 38-year-old
man with a huge abdominal mass
infiltrating the omentum.
Pathological diagnosis was ASPS.
He had metastases in both lungs and
the right atrium. Afterwards multiple
sessile polyps also appeared in
stomach and duodenum with diagnostic
biopsy of ASPS. Finally the
patient developed brain metastases
and died (13).
Primary gastrointestinal ASPS is
extremely rare. Only one case has
been reported in 2000 by Yaziji et al.,
a primary ASPS of the stomach in a
54-year-old Italian woman without
evidence of primary neoplasm elsewhere
ten years following the initial
diagnosis (14)."
may be something here will ring a bell.
Gastrointestinal metastases
Treatment of metastases in other locations.
Jump to
- Welcome to CureASPS.org!
- ↳ Guest Book
- ↳ Forum Issues and Suggestions
- News and Updates
- ↳ Personal Stories and Updates
- ↳ Success Stories
- ↳ Rest In Peace
- ↳ Anonymous Patient Updates
- ↳ Chinese group news
- ↳ Medical Publications
- ↳ Other Publications
- ↳ Sarcoma Meetings and Conferences
- ASPS Clinical Trials
- ↳ Other Clinical Trials
- ↳ COMPLETED - ARQ 197 Clinical Trial
- ↳ COMPLETED - Dana Farber Vaccine Clinical Trial (GVAX)
- ↳ Dasatinib
- ↳ Alisertib
- ↳ Cediranib
- ↳ Anlotinib
- ↳ Immune checkpoint inhibitors (ICI)
- ↳ Axitinib and Pembrolizumab (Keytruda) in Miami, US
- ↳ TECENTRIQ (atezolizumab) by Genentech
- ↳ Pfizer's PF-06801591
- ↳ Durvalumab+Tremelimumab at MDACC
- Symptoms and Diagnostics
- ↳ Symptoms
- ↳ Scan Types and Follow-Up
- ↳ Molecular Studies
- ↳ Pathology results
- Primary Tumor Treatment
- ↳ Resection
- ↳ Treatment of Non-Resectable Primary Tumor
- ↳ Radiation
- Systemic Treatment
- ↳ TKI
- ↳ Sutent (sunitinib)
- ↳ Pazopanib
- ↳ Сabozantinib (Cometriq)
- ↳ Sorafenib
- ↳ Chemotherapy
- ↳ Metronomic chemotherapy
- ↳ Temozolomide (Temodar)
- ↳ Side effects of systemic treatments
- ↳ Interferon alpha
- ↳ Immune checkpoint inhibitors ICI (PD-1 and PD-L1 targeting drugs)
- ↳ Keytruda
- ↳ Opdivo
- ↳ TECENTRIQ (atezolizumab)
- ↳ Toxicity, problems and potentiation strategies
- ↳ Treatment response criteria and evaluation/scanning problems/rare cases
- ↳ treatment discontinuation/re-treatment
- Metastatic Disease Treatment
- ↳ Local treatment modalities
- ↳ cryoablation
- ↳ Side effects/complications of the local ablations
- ↳ Radiosurgery
- ↳ Microwave ablation
- ↳ High intensity focused ultrasound (HIFU)
- ↳ Lung Metastases
- ↳ Laser assisted surgery
- ↳ Brain Metastases
- ↳ Bone Metastases
- ↳ Other Metastases
- ↳ Abdominal Metastases
- ↳ Liver metastases
- ↳ Heart Metastases
- ↳ Spinal metastases
- ↳ Adrenal metastases
- ↳ Pancreatic metastases
- Living with ASPS
- ↳ Insurance Coverage
- ↳ Second opinion from a sarcoma center
- ↳ Finanical assistance
- ↳ Diet and lifestyle
- ↳ Related studies
- ↳ Pain management
- ↳ Travel assistance